Aurinia raises 2026 revenue outlook as LUPKYNIS sales and operating cash flow grow
Market Chameleon (Fri, 30-Oct 8:26 AM)
Aurinia’s Patent Settlement with Teva Secures Voclosporin Exclusivity Until 2036
Market Chameleon (Thu, 20-Aug 9:42 AM)
